No Detail Found!

Comparative effect of ATT Alone and in Combination with Vitamin D on Physiological and Laboratory Parameters in Pulmonary Tb.

Author(s)
Fahad Azam Department of Pharmacology and Therapeutics, Shifa College of Medicine, Islamabad, Pakistan
Abida Shaheen Department of Pharmacology and Therapeutics, Shifa College of Medicine, Islamabad, Pakistan
Faisal Faiyaz Zuberi Department of Pulmonology, Ojha Institute of Chest Diseases, Dow University of Health Sciences, Karachi, Pakistan
Abstract
Objectives: To evaluate the role of adjuvant Vitamin D therapy on pulmonary tuberculosis with respect to disease severity. Objectives of this study were to assess and compare the levels of Vitamin D, C -reactive protein and ESR within and between both groups before and after therapy and time taken for sputum microscopy conversion. We also compared the effect of therapy on the severity of the disease within and between both groups after therapy. Study Design & Methods: 86 tuberculosis patients were enrolled after obtaining a written informed consent. They were divided into two groups; namely Group D (Patients with ATT and adjuvant Vitamin D) and Group P (Placebo group receiving normal saline injection). Two doses of Vitamin D I/M (0.6 million units) at baseline and at week 6 of the study along with standard ATT were given to the patients in D group. Normal saline injection along with standard therapy was given to the patients in Group P. Laboratory investigations were conducted at baseline and at Day 75 of the therapy and sputum microscopy examination fortnightly till sputum conversion. Results: In the D group, at Day 75 of therapy, adjuvant Vitamin D treatment significantly increased serum Vitamin D, serum calcium, Hemoglobin, BMI and significantly decreased ESR, CRP and total white blood cell count. In the Placebo group, anti tuberculous therapy significantly increased serum Calcium, BMI and significantly reduced ESR, CRP and total white blood cell count at Day 75 of therapy. The mean number of days for sputum conversion in Group D and P was 49 days and 61 days respectively. Conclusion: Adjuvant Vitamin D therapy plays a prominent role in the treatment of pulmonary tuberculosis as in treatment group it profoundly produced early sputum conversion by 12 days in comparison to Placebo group which received ATT alone.
Publication Details
Page(s) 92-98
DOI DOI not available
Published Journal: Journal of Dow University of Health Sciences, Volume: 9, Issue: 3, Year: 2015

Request the full text from PASTIC

References
WHO. 2004. TB/HIV: A Clinical Manual. Second Edition, WHO/HTM/TB/2004; 329.
MiglioriGB,BesozziG,GirardiE,KliimanK,LangeC,ToungoussovaeOS,FerraraG, 2007.Clinical and operational value of the extensively drug-resistant tuberculosis definition,Eur Respir J 30 623 -6
ShahNS,WrightA,BaiGH,BarreraL,BoulahbalF,Martín-CasabonaN, 2007.Worldwide Emergence of Extensively Drug-resistant Tuberculosis,Emerging Infectious Dis 13 380 -7
ZhangY,YewWW, 2009.Mechanisms of drug resistance in Mycobacterium tuberculosis,Int J Tuberc Lung Dis 13 1320 -30
Espinal,LaszloA,SimonsenL,BoulahbalF,KimSJ, 2001.Global Trends in Resistance to Antituberculosis Drugs,N Engl J Med 344 1294 -1303
MiglioriGB,HopewellPC,BlasiF,SpanevelloA,RaviglioneMC, 2006.Improving the TB case management: the International Standards for Tuberculosis care,Eur Respir J 28 687 -90
RaviglioneMC, 2007.The new Stop TB Strategy and the Global Plan to Stop TB,, 85 327 -
KaufmannSH, 2000.Is the development of a new tuberculosis vaccine possible,Nature Med 6 955 -60
Fabri1M,StengerS,ShinDM,YukJM,LiuPT,RealegenoS, 2011.Vitamin D isRequired for IFNã-Mediated Antimicrobial Activity of Human,Macrophages Sci Transl Med 3 -
TalatN,PerryS,ParsonnetJ,DawoodG,Hussain R. Vitamin D Deficiency and Tuberculosis,Progression, 2010.,Emerging Infectious Dis 16 853 -5
WejseC,OlesenR,RabnaP,KaestelP,GustafsonP,AabyP, 2007.Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls,Am J Clin Nutr 86 1376 -83
NursyamEW,AminZ,RumendeCM, 2006.The Effect of Vitamin D as Supplementary Treatment in Patients with Moderately Advanced Pulmonary Tuberculous Lesion,Acta Med Indones-Indones J Intern Med 38 3 -5
MartineauAR,TimmsPM,BothamleyGH,HanifaY,Islam K, 2011.High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial,The Lancet 377 242 -50
BakerM,DasD,VenugopalK., 2008.Tuberculosis associated with household crowding in a developed country,J Epidemiol Community Health 62 715 -21
HargreavesJR,BocciaD,EvansCA,AdatoM,PetticrewM,PorterJD, 2011.The social determinants of tuberculosis: from evidence to action,Am J Public Health 101 654 -62
AkhtarS,WhiteF,HasanR,RoziS,YounusM,AhmedF, 2007.Hyperendemic pulmonary tuberculosis in periurban areas of Karachi, Pakistan, -
KaryadiE,SchultinkJW,NelwanRH, 2000.Poor micronutrient status of active pulmonary tuberculosis patients in Indonesia,J Nutr 130 2953 -8
BassiliA,SeitaA,BaghdadiS,AlabsiA,AbdilaiI,AgboatwallaM, 2008.Diagnostic and treatment delay in tuberculosis in 7 countries of the Eastern Mediterranean Region,Infect Dis Clin Pract 16 23 -35
HasanZ,TanveerM,KanjiA,HasanQ,GhebremichaelS., 2006.Spoligotyping of Mycobacterium tuberculosis isolates from Pakistan reveals predominance of Central Asian Strain 1 and Beijing isolates,J Clin.Microbiol 44 1763 -8
BaumannH,GauldieJ., 1994.The acute phase response,Immunol Today 15 74 -80
1997.Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis,J Rheumatol 24 1477 -85
Osei-BimpongA,MeekJH, 2007.ESR or CRP ?A comparsion of their clinical utility,Hematol 12 353 -7
UstianowskiA,ShafferR,CollinS,WilkinsonRJ,DavidsonRN, 2005.Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London,J Infect 50 432 -7
Ho-PhamLT,NguyenND,NguyenTT,NguyenDH,BuiPK,NguyenVN, 2010.Association between vitamin D insufficiency and tuberculosis in a vietnamese population,BMC Infectious Dis 10 306 -
MehtaS,MugusiFM,BoschRJ,AboudS,UrassaW,VillamorE, 2013.Vitamin D status and TB treatment outcomes in adult patients in Tanzania: a cohort study,BMJ Open 3 e003703 -
SatoS,TaninoY,SaitoJ,NikaidoT,InokoshiY,FukuharaA, 2012.Relationship between 25-hydroxy vitamin D levels and treatment course of pulmonary tuberculosis,Respir Investig 50 40 -5
Brodie MJ, 1982.Effect of rifampicin and isoniazid on vitamin D metabolism,Clin Pharmacol Ther 32 525 -30
WejseC,GomesVF,RabnaP,GustafsonP,AabyP,LisseIM, 2009.Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebocontrolled trial,Am J Respir Crit Care Med 179 843 -50
BaigMA,IslamNU,IslamUU, 2009.Low Serum Vitamin D Associated with Tuberculosis,J Pak Orthoped Assoc 21 27 -32
CannellJJ,HollisBW, 2008.Use of vitamin D in clinical practice,Altern Med Rev 13 6 -20
SalahuddinN,AliF,HasanZ,RaoN,AqeelM,Mahmood F. Vitamin, 2013.D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis,BMC Inf Dis 13 22 -
0

Citations

0

Downloads

51

Views